Addex Pharmaceuticals Ltd/ CH0029850754 /
| 2022-02-03 12:00:00 AM | Chg. - | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 0.9900USD | - | 100 Turnover: - |
-Bid Size: - | -Ask Size: - | 12.93 mill.USD | - | - |
Assets
| 2015 IFRS in mill. CHF |
2016 IFRS in mill. CHF |
2017 IFRS in mill. CHF |
2018 IFRS in mill. CHF |
2019 IFRS in mill. CHF |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 27.6000 | ||||||
| Intangible Assets | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
| Long-Term Investments | .1000 | 0.0000 | 0.0000 | 0.0000 | 68.9000 | ||||||
| Fixed Assets | .1000 | 0.0000 | 0.0000 | 0.0000 | 639.9000 | ||||||
| Inventories | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
| Accounts Receivable | - | - | - | - | - | ||||||
| Cash and Cash Equivalents | 2.6000 | 1.4000 | 2.6000 | 41.7000 | 31.5000 | ||||||
| Current Assets | 2.8000 | 1.7000 | 3.1000 | 42.2000 | 32.4000 | ||||||
| Total Assets | 2.9000 | 1.7000 | 3.1000 | 42.2000 | 33 | ||||||
Liabilities
| 2015 IFRS in mill. CHF |
2016 IFRS in mill. CHF |
2017 IFRS in mill. CHF |
2018 IFRS in mill. CHF |
2019 IFRS in mill. CHF |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 1 | 1.2000 | 1 | 2.1000 | 4.2000 | ||||||
| Long-term debt | - | - | - | - | - | ||||||
| Liabilities to Banks | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
| Provisions | - | - | - | - | - | ||||||
| Liabilities | 1.2000 | 1.5000 | 1.7000 | 2.9000 | 7.5000 | ||||||
| Share Capital | 11 | 11.6000 | 13.4000 | 28.6000 | 32.8000 | ||||||
| Total Equity | 1.6000 | .2000 | 1.3000 | 39.2000 | 25.5000 | ||||||
| Minority Interests | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
| Total liabilities equity | 2.9000 | 1.7000 | 3.1000 | 42.2000 | 33 | ||||||
Income Statement
| 2015 IFRS in mill. CHF |
2016 IFRS in mill. CHF |
2017 IFRS in mill. CHF |
2018 IFRS in mill. CHF |
2019 IFRS in mill. CHF |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | .8000 | .4000 | .5000 | 6.7000 | 2.9000 | ||||||
| Depreciation (total) | - | - | - | - | - | ||||||
| Operating Result | -3.9000 | -3.1000 | -3.2000 | -1.4000 | -14.6000 | ||||||
| Interest Income | - | - | - | - | - | ||||||
| Income Before Taxes | -4.2000 | -3.1000 | -3.3000 | -1.6000 | -14.8000 | ||||||
| Income Taxes | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
| Minority Interests Profit | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
| Net Income | -4.2000 | -3.1000 | -3.3000 | -1.6000 | -14.8000 | ||||||
Per Share
Cash Flow
| 2015 IFRS in mill. CHF |
2016 IFRS in mill. CHF |
2017 IFRS in mill. CHF |
2018 IFRS in mill. CHF |
2019 IFRS in mill. CHF |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | -2.6000 | -2.7000 | -2.1000 | 1.8000 | -9.5000 | ||||||
| Cash Flow from Investing Activities | .4000 | 0.0000 | 0.0000 | -.0600 | -.0400 | ||||||
| Cash Flow from Financing | 2.9000 | 1.5000 | 3.4000 | 37.4000 | -.5000 | ||||||
| Decrease / Increase in Cash | .7000 | -1.2000 | 1.2000 | 39.1000 | -10 | ||||||
| Employees | 8 | 10 | 8 | 17 | 23 | ||||||
